Documento di consenso ANMCO/AICO/AIOM:
Snodi clinico-gestionali in ambito cardioncologico

Luigi Tarantini1 (Coordinatore), Michele Massimo Gulizia2 (Coordinatore),
Andrea Di Lenarda3 (Coordinatore), Nicola Maurea4 (Coordinatore), Maurizio Giuseppe Abrignani5,
Irma Bisceglia6, Daniella Bovelli7, Luisa De Gennaro8, Donatella Del Sindaco9, Francesca Macera10,
Iris Parrini11, Donatella Radini3, Giulia Russo3, Angela Beatrice Scardovi12, Alessandro Inno13

1S.C. Cardiologia, Ospedale San Martino, Azienda ULSS 1, Belluno

2U.O.C. Cardiologia, Ospedale Garibaldi-Nesima, Azienda di Rilievo Nazionale e Alta Specializzazione “Garibaldi”, Catania

3S.C. Centro Cardiovascolare, Azienda Sanitaria Universitaria Integrata, Trieste

4S.C. Cardiologia, Istituto Nazionale Tumori, IRCCS Fondazione “G. Pascale”, Napoli

5U.O.C. Cardiologia-UTIC, Ospedale S. Antonio Abate, Erice (TP)

6S.C. Cardiologia 2, A.O. San Camillo-Forlanini, Roma

7S.C. Cardiologia, A.O. Santa Maria, Terni

8S.C. Cardiologia-UTIC, Ospedale San Paolo, Bari

9U.O. Cardiologia, Ospedale Nuovo Regina Margherita, Roma

10S.C. Cardiologia 2, ASST Grande Ospedale Metropolitano Niguarda, Milano

11Cardiologia, Ospedale Mauriziano, Torino

12S.C. Cardiologia, Ospedale Santo Spirito, Roma

13S.C. Oncologia, Ospedale Sacro Cuore Don Calabria, Negrar (VR)

Revisori del Documento

Sandro Barni, Iolanda Enea, Stefania Gori, Chiara Lestuzzi, Stefano Oliva, Carmine Pinto, Sonia Tosoni

Consensus Document Approval Faculty

in Appendice 1

In Italy, cardiovascular diseases and cancer are the leading causes of death. Both diseases share the same risk factors and, having the highest incidence and prevalence in the elderly, they often coexist in the same individual. Furthermore, the enhanced survival of cancer patients registered in the last decades and linked to early diagnosis and improvement of care, not infrequently exposes them to the appearance of ominous cardiovascular complications due to the deleterious effects of cancer treatment on the heart and circulatory system. The above considerations have led to the development of a new branch of clinical cardiology based on the principles of multidisciplinary collaboration between cardiologists and oncologists: Cardio-oncology, which aims to find solutions to the prevention, monitoring, diagnosis and treatment of heart damage induced by cancer care in order to pursue, in the individual patient, the best possible care for cancer while minimizing the risk of cardiac toxicity. In this consensus document we provide practical recommendations on how to assess, monitor, treat and supervise the candidate or patient treated with potentially cardiotoxic cancer therapy in order to treat cancer and protect the heart at all stages of the oncological disease.

Key words. Cancer; Cardio-oncology; Cardiotoxicity; Cardiovascular disease.